These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6502916)

  • 21. Impaired cardiovascular reflexes precede deoxycorticosterone acetate-salt hypertension.
    Veelken R; Hilgers KF; Ditting T; Leonard M; Mann JF; Geiger H; Luft FC
    Hypertension; 1994 Nov; 24(5):564-70. PubMed ID: 7960014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular calcium and altered vascular responsiveness in the deoxycorticosterone acetate-salt rat.
    Soltis EE; Field FP
    Hypertension; 1986 Jun; 8(6):526-32. PubMed ID: 3710558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of renal sympathetic activity with potassium supplement in DOCA-salt rats.
    Sato Y; Fujita T
    Jpn Heart J; 1984 Mar; 25(2):253-61. PubMed ID: 6748225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympathetic hyperactivity during hypothalamic stimulation in spontaneously hypertensive rats.
    Takeda K; Buñag RD
    J Clin Invest; 1978 Sep; 62(3):642-8. PubMed ID: 690189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic central GABAergic stimulation attenuates hypothalamic hyperactivity and development of spontaneous hypertension in rats.
    Sasaki S; Nakata T; Kawasaki S; Hayashi J; Oguro M; Takeda K; Nakagawa M
    J Cardiovasc Pharmacol; 1990 May; 15(5):706-13. PubMed ID: 1692929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild DOCA-salt hypertension: sympathetic system and role of renal nerves.
    Kandlikar SS; Fink GD
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1781-7. PubMed ID: 21357502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypotensive responses to centrally administered taurine in DOCA-salt hypertensive and spontaneously hypertensive rats.
    Inoue A; Takahashi H; Lee LC; Sasaki S; Takeda K; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1986 Dec; 50(12):1215-23. PubMed ID: 3820530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmented vasodepressor and sympathetic responses to intracerebroventricular injections of diltiazem, a calcium channel blocker, in DOCA-salt hypertensive rats.
    Takahashi H; Okabayashi H; Suga K; Iyoda I; Matsuzawa M; Ikegaki I; Yoshimura M; Ijichi H
    J Hypertens Suppl; 1986 Dec; 4(6):S156-9. PubMed ID: 3475411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retardation of the development of hypertension in DOCA salt rats by taurine supplement.
    Inoue A; Takahashi H; Lee LC; Sasaki S; Kohno Y; Takeda K; Yoshimura M; Nakagawa M
    Cardiovasc Res; 1988 May; 22(5):351-8. PubMed ID: 3191519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    Nakata T; Takeda K; Itho H; Hirata M; Kawasaki S; Hayashi J; Oguro M; Sasaki S; Nakagawa M
    Am J Hypertens; 1989 Aug; 2(8):625-30. PubMed ID: 2570597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced induction of gastric carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in deoxycorticosterone acetate-NaCl hypertensive rats and its inhibition by potassium chloride.
    Tatsuta M; Iishi H; Baba M; Taniguchi H
    Cancer Res; 1991 Jun; 51(11):2863-6. PubMed ID: 2032226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Streptozotocin diabetic rats are hypertensive despite reduced hypothalamic responsiveness.
    Buñag RD; Tomita T; Sasaki S
    Hypertension; 1982; 4(4):556-65. PubMed ID: 6218080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1.
    Berthon N; Laurant P; Hayoz D; Fellmann D; Brunner HR; Berthelot A
    Can J Physiol Pharmacol; 2002 Jun; 80(6):553-61. PubMed ID: 12117304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL; Delcayre C; Besnard JC; Paolaggi F; Mouas C; Swynghedauw B
    Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive effects of low molecular mass potassium alginate extracted from brown algae on DOCA salt-induced hypertension in rats.
    Chen YY; Ji W; Du JR; Yu DK; He Y; Yu CX; Li DS; Zhao CY; Qiao KY
    Biomed Pharmacother; 2010 Apr; 64(4):291-5. PubMed ID: 19932586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of hypothalamo-sympathetic nerve system to maintain high blood pressure in DOCA hypertensive rats.
    Takeda K; Sasaki S; Kaimasu I; Yoshimura M; Nakagawa M; Ijichi H; Bunag RD
    Jpn Circ J; 1980 May; 44(5):409-10. PubMed ID: 7392202
    [No Abstract]   [Full Text] [Related]  

  • 37. Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1995 Mar; 8(3):287-93. PubMed ID: 7794579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central attenuation of baroreflex precedes the development of hypertension in DOCA-salt-treated rats.
    Takeda K; Nakamura Y; Oguro M; Kawasaki S; Hayashi J; Tanabe S; Nakata T; Lee LC; Sasaki S; Nakagawa M
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):23S-25S. PubMed ID: 3415800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
    O'Donaughy TL; Brooks VL
    Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
    Sato Y; Ando K; Fujita T
    Hypertension; 1987 Jan; 9(1):81-7. PubMed ID: 2878880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.